Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Stock Quote Today & Recent News Royalty Pharma plc RPRX

Healthcare
Royalty Pharma plc is a buyer of biopharmaceutical royalties and a funder of innovation across the biopharmaceutical industry. The Company collaborates with innovators from academic institutions, research hospitals and non-profits through small and mid-cap biotechnology companies to global pharmaceutical companies. Its portfolio consists of royalties on over 35 commercial products, including... see more
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >

Current News (NDAQ:RPRX)

Royalty Pharma to Present at TD Cowen's 44th Annual Health Care Conference

GlobeNewswire February 28, 2024

Royalty Pharma Reports Q4 and Full Year 2023 Results

GlobeNewswire February 15, 2024

Royalty Pharma To Announce Fourth Quarter And Full Year 2023 Financial Results On February 15, 2024

GlobeNewswire January 30, 2024

Royalty Pharma Announces Dividend Increase

GlobeNewswire January 19, 2024

Royalty Pharma Highlights Accomplishments and Provides Business Update at 42nd Annual J.P. Morgan Healthcare Conference

GlobeNewswire January 8, 2024

Royalty Pharma to Present at the Evercore ISI 6th Annual HealthCONx Conference

GlobeNewswire November 27, 2023

Royalty Pharma and Teva Collaborate to Further Accelerate Olanzapine Lai Program

GlobeNewswire November 13, 2023

Teva and Royalty Pharma Collaborate to Further Accelerate Olanzapine LAI Program

Business Wire November 13, 2023

Royalty Pharma Reports Third Quarter 2023 Results

GlobeNewswire November 8, 2023
View More News ››

Opinion & Analysis (NDAQ:RPRX)

No current opinion is available.
View More Opinion ››

Bullboard Posts (NDAQ:RPRX)

Saw this recommendation this morning

Over 50% return in the past 4 days. This guy probably know something about the stock. FDA monday! http://www.nvest.me/companies/RPRX...
Tracker007 - November 27, 2015

RE:FDA ACCEPTS NDA TODAY

Jk.  From RVX  to BTI to Repros. I bought in on Friday.   I agree.....we just have to sit this out and wait. Gltu
craighenry - June 28, 2015

FDA ACCEPTS NDA TODAY

Just gotta wait now!
Jkj193741 - April 1, 2015

A game changer

Boost testosterone for the first time by a pill rather than a shot, gel, spray etc. at least 2 billion potential market.
Jkj193741 - April 17, 2013

RPRX will probably become the stock to see this ye

Has any person taken a look at the articles being issued? Fascinating information that will assist any investor or trader...  ...
david.smith76 - February 21, 2013

Pressure

The pressure is on to get this back up
Quest4Fire - August 23, 2010
View more Bullboard ››

Canada Jetlines Operations Ltd

Canada Jetlines Operations Ltd

Canada Jetlines Operations Ltd. is a Canada-based leisure-focused air carrier. The Company's principal business activities ...
View More »